CIK: 1247653 - Address: C/o Halozyme Therapeutics, Inc., 11388 Sorrento Valley Road, San Diego, CA 92121
33 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret2126-001-6-13-17-6
S%wins54624669818165

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/21/14 17:07
8/19/14
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagPatton John StuartCADS.d-7479.9613-75-29180D6337-353450-3-1134-96180
9/16/13 18:46
9/13/13
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagPatton John StuartCADS.dm-6859.1313-75-33155D5158654230225-188164648-1
11/18/08 15:11
11/14/08
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS.d-34.374-10314D-72-32-14366-84-6-425651111
10/18/07 16:06
10/16/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1369.043-15-5015D368236-1-8-714-2-20-6-27-35-45
10/11/07 16:04
10/9/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1308.693-15-3330D3262350-115-3-11542-22-34-42
10/2/07 19:15
10/2/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1338.905-15-2545D34425910-760-3-1-4-23-20-30-17
9/26/07 16:38
9/25/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1348.944-15-2060D351247706-113-2-1-20-20-29-26
9/19/07 19:21
9/18/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1568.933-17-1975D3522543-1189-132-10-33-33-22
7/11/07 16:44
7/10/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1969.786-20-1892D4582722912-5-4101-1-8-13-36-33
6/26/07 21:38
6/26/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-748.986-8-7112D402287227-13-17-11-102710-22-40
6/26/07 21:38
6/26/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-1028.666-12-9121D402287227-13-17-11-102710-22-40
6/19/07 20:27
6/19/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-20510.253-20-13132D462323472121-12-1-11-3-15-34-40
6/14/07 16:04
6/12/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-20110.052-20-12152D45634159280-3-3-15-10-13-34-46
5/30/07 17:01
5/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-20510.273-20-10172D4263102722314-2-5-2-24-12-18-29-53
5/23/07 18:01
5/23/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-15810.503-15-7192D481308309122130-2-2-1-7-20-24-53
5/23/07 16:17
5/22/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-21110.563-20-9207D481308309122130-2-2-1-7-20-24-53
4/19/07 16:51
4/18/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-2289.130-25-11212D
4/12/07 17:06
4/11/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-2158.620-25-10237D
4/5/07 16:12
4/4/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-2098.360-25-9262D
3/28/07 18:50
3/28/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS.a-2108.400-25-8287D
3/28/07 18:01
3/28/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-2108.400-25-806D
3/21/07 17:10
3/21/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS-2158.590-25-7312D
3/16/07 16:36
3/14/07
HTIHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagPatton John StuartCADS.m-2008.010-25-7337D
5/18/06 15:43
5/15/06
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-3320.2133-2-731B-1-4-9-17-23-43
3/7/06 14:33
3/7/06
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS.d-7619.8033-4-1558B2031-13-42
1/30/06 17:11
1/27/06
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-44022.0033-20-3552B-1-258-16-34
1/17/06 11:50
1/13/06
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-40120.0431-20-4514B-3-434-19-28
5/10/05 15:19
5/10/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-2514.4710-2-522I86-27-8-235-23-28152020955
3/16/05 13:44
3/14/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS.d-2114.3727-101,074I177-260-22-13-15-32-7-10-4202330
12/16/04 14:08
12/15/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-6619.4226-3-612I1425073132331411-4-31-6-14
3/8/04 21:37
3/4/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-44422.1826-20-4507I953891067335272622-6-73-7-39-31
2/12/04 17:36
2/10/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-40020.0023-20-4527I40287138413410134-329-5-37-6
1/14/04 19:50
1/13/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsPatton John StuartCADOChief ScS-36418.1912-20-4547I411292243937291221217-33

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact